Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in …

NL Albert, M Weller, B Suchorska, N Galldiks… - Neuro …, 2016 - academic.oup.com
This guideline provides recommendations for the use of PET imaging in gliomas. The review
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

MJ van den Bent, JS Wefel, D Schiff… - The lancet …, 2011 - thelancet.com
Although low-grade gliomas (LGG) have a less aggressive course than do high-grade
gliomas, the outcome of these tumours is ultimately fatal in most patients. Both the tumour …

Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas

FG Dhermain, P Hau, H Lanfermann… - The Lancet …, 2010 - thelancet.com
Imaging techniques are important for accurate diagnosis and follow-up of patients with
gliomas. T1-weighted MRI, with or without gadolinium, is the gold standard method …

Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods

R Ahmed, MJ Oborski, M Hwang… - Cancer management …, 2014 - Taylor & Francis
Malignant gliomas consist of glioblastomas, anaplastic astrocytomas, anaplastic
oligodendrogliomas and anaplastic oligoastrocytomas, and some less common tumors such …

Value of 11C-methionine PET in imaging brain tumours and metastases

AWJM Glaudemans, RH Enting… - European journal of …, 2013 - Springer
Abstract 11 C-methionine (MET) is the most popular amino acid tracer used in PET imaging
of brain tumours. Because of its characteristics, MET PET provides a high detection rate of …

Molecular imaging of gliomas with PET: opportunities and limitations

C la Fougere, B Suchorska, P Bartenstein… - Neuro …, 2011 - academic.oup.com
Neuroimaging enables the noninvasive evaluation of glioma and is considered to be one of
the key factors for individualized therapy and patient management, since accurate diagnosis …

MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?

NL Jansen, V Graute, L Armbruster… - European journal of …, 2012 - Springer
Purpose Since differentiation between low-grade glioma (LGG) and high-grade glioma
(HGG) remains challenging according to MRI criteria alone, we investigated the …

Non-invasive metabolic imaging of brain tumours in the era of precision medicine

MM Kim, A Parolia, MP Dunphy… - Nature reviews Clinical …, 2016 - nature.com
The revolution in cancer genomics has uncovered a variety of clinically relevant mutations in
primary brain tumours, creating an urgent need to develop non-invasive imaging biomarkers …

Multimodality assessment of brain tumors and tumor recurrence

WD Heiss, P Raab, H Lanfermann - Journal of Nuclear Medicine, 2011 - Soc Nuclear Med
Neuroimaging plays a significant role in the diagnosis of intracranial tumors, especially brain
gliomas, and must consist of an assessment of location and extent of the tumor and of its …

Prognostic value of early [18F] fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme

MD Piroth, M Pinkawa, R Holy, J Klotz, S Nussen… - International Journal of …, 2011 - Elsevier
PURPOSE: Early detection of treatment response in glioma patients after
radiochemotherapy (RCX) is uncertain because treatment-related contrast enhancement in …